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Three recombinant human apoferritin variants were added to ferrous iron and the amount of lipid peroxidation produced by hydrogen peroxide 
was studied. Tbe H-apofer~tin had the strongest ~n~bito~ effect on lipid ~roxidation, probably due to its ferroxidase activity. The L-apoferritin 
inhibited lipid peroxidation slowly and only at neutral pH. The H-mutant 91, deleted of the last 22 C-terminal amino acids, and which is not able 
to form an iron core, had minimal effects on iron lipid peroxidation. It was concluded that both ferro-oxidase and iron mineralization activities 
are necessary for ferritin iron detoxifying action. 
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1. INTRODUCTION 
Ferritin is composed of 24 subunits of two types 
(named H and L) which co-assemble in a protein shell 
enveloping a polynuclear ferric hydroxide similar to the 
mineral ferrihydrite [ 11. The structure suggests that fer- 
ritin protein keeps iron in a bioavailable and non-toxic 
form which does not produce free radicals. However, 
experimental evidence that ferritin acts as an iron 
detoxifying agent is elusive: it was shown that ferritin 
oxidizes and incorporates iron in a reaction that pro- 
duces few, and probably non-toxic, free radicals [2], 
while various studies showed that ferritin-iron is 
available to the catalysis of free radical formation when 
in the presence of reducing agents B-71. The studies of 
in vivo iron-detoxifying activity are complex as they in- 
volve the understanding of the iron forms that generate 
free radicals. In vitro iron toxicity may be studied by the 
Haber and Weiss reaction, and by monitoring the 
peroxidation of Iipids in the presence of iron and 
hydrogen peroxide [5,7]. In vitro and aerobically apo- 
ferritin takes up iron(D) by inducing its oxidation and 
mineralization inside the cavity [ l&10]. This reaction 
has not been fully elucidated, and its effects on iron in- 
duced lipid peroxidation have not been studied. 
nant L-chain which lacks such activity [ 101, and an H- 
chain mutant deleted of the last 22 C-terminal anino 
acids, named 91, which differs from the two in not be- 
ing able to form a stable iron core [9]. These apofer- 
ritins were studied for their capacity to affect iron- 
mediated lipid peroxidation. It was found that H-wild- 
type reduced lipid peroxidation at neutral and acidic 
pH, the L-wild-type reduced it slowly and only at 
neutral pH, while the H-mutant 91 was essentially non- 
effective. The results indicate that ferritin shell has an 
inhibitory activity on iron induced lipid peroxidation, 
which is linked to its capacity to oxidize iron and to 
form a stable iron core. 
2. MATERIALS AND METHODS 
2.1. Ferritins and rnut~~t~ 
Recombinant human L-ferritin with the first two N-terminal amino 
acids modified from Ser-Ser with Asp-Pro, and previously named 
rLFo in [IO], recombinant human H-ferritin and the H-mutant 91 
were overexpressed in E. coii and purified as previously described 
[9,10]. Iron was removed from the purified ferritins by dithionite 
reduction and chelation as described in [lo). The apoferritins had ab- 
sorbance ratios at 280~260 nm of more than 1.3. 
2.2. Lipid peroxidation 
We analyzed three variants of human ferritins with 
different characteristics: the recombinant H-chain, 
which has a ferroxidase activity [9,ll, 121, the recombi- 
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The liposomes were prepared according to the procedure described 
in 1131: egg pbosphatidyl choline (Sigma) dissolved in chloroform was 
dried, and resuspended in water at a concentration of 20 mg/ml. 
After 60 min resting at 4”C, it was sonicated with 10 pulses of 30 s. 
The liposomes were stored up to 4 weeks at 4°C. The lipid peroxida- 
tion reactions were performed as in [ 141, in 50 mM Hepes at the stated 
pH values, and the stock ferrous ammonium sulfate solution in water 
was prepared immediately before use. The reaction mixtures (0.15 ml} 
contained 1 mg/ml phospholipid tiposomes, 0.1 mM HZ&, 0.2 mM 
Fe(H) and sample. After IO min incubation at 37°C to induce 
Iiposome peroxidation and formation of m~ondi~dehyde (MDA), 
Published by Elsevier Science Publishers B. K (Biomedical Division) 
00145793/90/$3.50 0 1990 Federation of European Biochemical Societies 119 
Volume 277, number 1,2 FEBSLETTERS December 1990 
the reaction was blocked by addition of 0.4 M HCI, 4.25% 
trichloroacetic acid final concentrations. Then 0.02 mM desferriox- 
amine, 0.05% butylated hydroxytoluene, 0.33% thiobarbituric acid 
(final concentrations) were quickly added, the samples incubated for 
20 min in boiling water to allow the development of the reaction bet- 
ween malondialdehyde adducts and thiobarbituric acid, chilled in an 
ice bath for 10 min and centrifuged for 5 min at 10 OOOxg. The 
amount of thiobarb~turi~ acid-reactive oxidation products (TBAR) 
was detected by optical reading at 532 nm. As reference solutions we 
used the reaction mixtures without iron. 
2.3. Ferritin iron uptake 
It was performed as described in [lo]. The apoferritins (50 &g/ml, 
0.1 PM) in 0.05 M Hepes buffer were incubated at 37°C with 0.2 mM 
freshly made ferrous ammonium sulfate. At intervals, samples were 
taken and the absorbance was read at 310 nm, or after the addition 
of 2,2’-bipyridine (Baker), 0.5 mM final concentration, and the ab- 
sorbance read at 520 nm, or analyzed for MDA formation as describ- 
ed above. 
3. RESULTS AND DISCUSSION 
3.1. Effects of apoferritins addition on iron-mediated 
lipid peroxidation 
As an index of iron toxicity, we analyzed the amount 
of phospholipid MDA adducts (TBAR) produced by 
mixtures of iron and hydrogen peroxide [5,7]. The pro- 
teins were added to the Fe(II)/HzOz mixture: the H- 
apoferritin reduced MDA formation by about 30% 
while L-apoferritin had no detectable ffect (Table I). 
Desferrioxamine reduced by 35% the MDA formation. 
Desferrioxamine and H-apoferritin had an additive ac- 
tion and together reduced the reaction by about 70~0. 
Bovine serum albumin, used as a protein contro1, had 
no effect. Further studies (not shown) indicated that the 
H-apoferritin inhibitory effect on MDA formation 
Table 1 
Effects of ferritins on iron-mediated lipid peroxidation 
Samples A532nm Lipid perox. 
(@Jo) 
rHF-Fe 0.006 ( + 0.003) 3 
rLFo-Fe 0.003 ( + 0.002) 1 
Fe2 + 0.204 ( rt 0.023) 100 
Fe’+ + Apo-rHF 0.142 (it 0.005) 71 
Fe’+ + Apo-rLFo 0.208 ( rt 0.014) >100 
Fe2 + + BSA 0.230 (?O.Oll) >I00 
Fe’ + + DFO 0.132 (f0.014) 65 
Fe’+ + DFO + Apo-rHF 0.061 (i’O.002) 30 
Fe”* + DFO + Apo-rLFo 0.153 (kO.002) 75 
Fe’+ + DFO + BSA 0.184 (+0.004) 90 
Reaction mixtures in 50 mM Hepes, pH 7.0, containing 0.2 mM 
ferrous ammonium sulfate, 0.1 mM HzOz, 1 mg/ml phospholipids, 
were added to 50 &g/ml of recombinant L (rLFo), recombinant H 
(rHF) apoferritins, bovine serum albumin (BSA) or to 0.4 mM 
desferrioxamine (DFO), incubated for 10 min at 37°C and then 
treated for TBA reactivity as indicated in the text. The samples rHF- 
Fe and rLFo-Fe consisted of H and L ferritins previously loaded with 
2000 iron atoms. Means rt SE of 4 experiments. 
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ranged between 12 and 36% in the concentration range 
0.02-0.2 mglml, the desferrioxamine between 35 and 
43% in the range 0.4-4.0 mM, while L-ferritin and 
albumin showed no significant effects up to a concen- 
tration of 0.2 mg/ml. A complete inhibition of MDA 
formation was obtained by previous incubation of apo 
H- and L-ferritins with Fe(H) for 18 h at pH 7.0, i.e. by 
reconstitution of the iron cores, and in absence of Fe(H) 
(rHF-Fe and rLFo-Fe in Table I). These findings in- 
dicate that ferritin-iron does not induce lipid peroxida- 
tion, and thus is not toxic in aerobic conditions, and 
that the H-ferritin-linked ferroxidase activity has an in- 
hibitory effect on MDA formtion, in keeping with the 
lower reactivity of Fe(II1) than Fe(I1) in the Heber and 
Weiss reactions. 
3.2. Kinetics effects of apoferritins on iron-mediated 
lipid perox~dati~~ 
Further experiments were performed at pH 6.5 and 
6.0, conditions in which iron autoxidation is minimized 
and the ferritin ferroxidase activity is more evident [9]. 
We studied the kinetics of iron uptake following the 
formation of ferric iron core at 310 nm reading, the 
disappearance of Fe(B) at 520 nm reading after addi- 
tion of 2,2’-bipyridine and, in addition, we monitored 
the capacity of the mixture to induce MDA formation 
by incubating aliquots with Hz02 and phospholipids, 
and then detecting TBAR at 532 nm. In the absence of 
apoferritin during 30 min incubation, iron was not ox- 
idized and the MDA formation capacity did not change 
appreciably either at pH 6.5 (not shown) or at pH 6.0 
(Fig. IA). The addition of L-apoferritin did not inhibit 
the formation of MDA (Fig. 1B). In contrast H- 
apoferritin readily induced both the decrease of MDA 
formation and iron oxidation, which reached plateau 30 
min at pH 6.0 (Fig. 1C). Thus it appeared that MDA 
formation decreased with decreasing concentration of 
Fe(II), suggesting that Fe(I1) is the active form. 
However, the Haber and Weiss reactions indicate 
that also Fe(II1) is able to react H202, but with a reac- 
tivity dependent upon the type of complex it forms, e.g. 
Fe(III)-NTA or Fe(III)-EDTA are highly reactive 
[15,16], while ferrioxamine [17,18] , Fe(III)-transferrin 
[19,20] or Fe-ferritin (see above) are not reactive. 
Previous studies identified transient 
mono(oligo)nuclear Fe(II1) forms during the ferritin 
iron uptake f21,22] of unknown chemical reactivity 
with H202. We studied a H-ferritin mutant which lacks 
the capacity to form a stable iron core. This mutant, 
named 91, is deleted of the last 22 C-terminal amino 
acids. We previously showed that it assembles in the 
24-mer protein shell, has ferroxidase activity, but is 
unable to incorporate iron and to keep it in solution [9]. 
It was expected that by reacting with Fe(I1) this mutant 
induces the accumulation of unstable oligonuclear 
Fe(III), as suggested by previous finding that upon pro- 
longed incubation with iron the protein precipitates [9]. 
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Fig. 1. Kinetics of ferritin iron uptake in 50 mM Hepes, pH 6.0. (A) 
Control in absence of ferritins. (B) In the presence of L-apoferritin. 
(C) In the presence of H-apoferritin. The reactions were monitored 
for iron oxidation by reading absorbance at 310 nm; for the presence 
of ferrous iron, by chelation with 2,2’-bipyridine and then reading at 
520 nm; and for MDA formation after incubation of the aliquots with 
HzOz, phospholipids and TBA, as described in the text, and then 
reading at 532 nm. 
Reactions at pH 6.0 and 6.5 showed that mutant 91 in- 
duced iron oxidation, even though less effectively than 
H-wild-type, while it decreased only marginally the iron 
lipid-peroxidating activity (Fig. 2A and B). Moreover 
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Fig. 2. Experiments as in Fig. 1. (A) H-mutant 91 at pH 6.5. (B) 
Mutant 91 at pH 6.0. (C) H-Apoferritin at pH 6.5. 
we found transient conditions during the H-ferritin iron 
uptake (e.g. at 30 min at pH 6.5) in which Fe(I1) was 
undetectable while MDA formation capacity was still 
present (Fig. 2C). In fact, the addition of 0.1 mM 
hydrogen peroxide to this sampIe induced a release of 
Fe(D) accounting for about 30% of the total iron add- 
ed, as measured by the increase of 0.090 absorbance 
121 
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units at 520 nm after 2,2’-bipyridine addition. After a 
further 18 h of incubation, the addition of hydrogen 
peroxide had no effect either on MDA formation or the 
release of Fe(I1) (not shown). Thus, the study of mutant 
91 of H-wild-type indicated that iron oxidation is not 
sufficient to abolish its toxicity, since the Fe(III) which 
is not in the mature iron core can react with hydrogen 
peroxide and produce lipid peroxidation. 
In conclusion, the present study shows that ferritin, 
while taking up iron, reduces its toxicity, and this reduc- 
tion is due to both its ferro-oxidase activity and to its 
biomineralization capacity. 
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